The investigation by Kuehn Law into Vaxcyte, Inc. for potential breaches of fiduciary duties suggests legal challenges that could negatively impact investor confidence and the stock price in the short term. The possibility of shareholder damages and corporate governance reforms adds to the uncertainty.